Joint research led by Yu Toyoshima and Yuichi Iino of the University of Tokyo has demonstrated individual differences in and successfully extracted commonalities from the whole-brain activity of roundworms.
AI drug discovery company Genesis Therapeutics wins $200m in Series B round – Pharmaceutical Technology
The funds will go toward its Genesis Exploration of Molecular Space (GEMS) technology – a platform that uses generative and predictive AI technology to accelerate